What is a micro‑pacemaker?

What is a Micro-Pacemaker?

A micro-pacemaker (also called a leadless pacemaker) is a miniaturized, self-contained pacemaker device that is implanted directly inside the right ventricle of the heart via catheter through the femoral vein, eliminating the need for traditional pacing leads and a subcutaneous pocket. The most widely studied example is the Micra Transcatheter Pacing System 1, 2.

Key Characteristics

Design and Implantation

• Size: Dramatically smaller than conventional pacemakers due to advances in miniaturization technology and battery chemistry 1
• Delivery method: Transcatheter approach through the femoral vein, with the device deployed directly onto the right ventricular endocardium 1, 3
• Components: Fully self-contained unit with no separate pulse generator pocket or transvenous leads 2

Current Technology

The commercially available systems include:

• Micra™ series (Medtronic): Single-chamber ventricular pacing system 4, 2
• Aveir™ system (Abbott): Modular design enabling the first fully leadless dual-chamber pacing 4

Clinical Advantages

Complication Avoidance

The primary benefit is elimination of lead-related and pocket-related complications that plague conventional pacemaker systems 4, 2:

• No lead fractures
• No lead endocarditis
• No pocket infections
• No subcutaneous pocket hematomas
• No lead dislodgement issues (though device dislodgement can still occur)

Safety Profile

Long-term data through 60 months demonstrates a major complication rate of only 4.5%, significantly lower than the 8.5% rate seen with transvenous systems 5. Notably, zero infections have been reported over the entire follow-up duration 5.

Indications

Current Use

Micro-pacemakers are indicated for patients requiring single-chamber ventricular pacing (VVI/VVIR mode) 1. They are particularly valuable in:

• Patients at high infection risk 4
• Patients with venous access limitations or abnormalities 4, 3
• Congenital or acquired cardiac/vascular abnormalities 3
• Previous tricuspid valve surgery 3
• Post-heart transplantation patients 3

Common Clinical Scenarios

Based on real-world registry data, typical indications include 3:

• Third-degree atrioventricular block (30.3%)
• Permanent atrial fibrillation with bradycardia (45.5%)
• Sinus node dysfunction (21.2%)

Performance Characteristics

Electrical Parameters

Electrical measurements remain stable over long-term follow-up 3, 5:

• Mean pacing capture threshold: 0.57 ± 0.32 V
• Pacing impedance: 580 ± 103 Ohms
• R-wave sensing: 10.62 ± 4.36 mV

Battery Longevity

Despite miniaturization, these devices aim to provide similar battery longevity to conventional pacemakers through advances in battery chemistry 1.

Limitations and Considerations

Current Constraints

• Single-chamber pacing only with most current devices (though dual-chamber systems are emerging) 4
• Cannot provide atrial pacing in current widespread models
• Not suitable for patients requiring AV synchrony unless using newer modular dual-chamber systems 4

End-of-Life Management

A key challenge remains the management of devices at end-of-life or malfunction 4, 6. Options include:

• Device extraction (though more complex than lead extraction)
• Leaving inactive devices in place and implanting new ones
• Protocols are still evolving for these scenarios 6

Rare Complications

While overall complication rates are low, potential issues include 7:

• Inadvertent left ventricular placement (through undiagnosed patent foramen ovale)
• Device dislodgement
• Elevated pacing thresholds (30.6% of system revisions) 5

System Revision Rates

The all-cause system revision rate at 60 months is 4.9%, significantly lower than conventional systems (3.2% vs. 6.6% at 36 months) 5. Revisions are primarily for:

• Device upgrades (41.2%)
• Elevated thresholds (30.6%)

Future Directions

Emerging developments include 4, 6:

• Fully leadless cardiac resynchronization therapy (CRT) systems
• Integration with subcutaneous implantable cardioverter-defibrillators (ICDs)
• Energy-harvesting technologies to extend battery life
• Expanded dual-chamber pacing capabilities

The micro-pacemaker represents a paradigm shift in cardiac pacing, fundamentally changing device therapy by eliminating the most common sources of complications while maintaining equivalent therapeutic efficacy 2.